APEIRON Biologics AG is a private biotechnology company based in Vienna that specializes in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases.

APEIRON’s cancer drug APN311 (Dinutuximab beta, Qarziba®) has marketing approval in the EU for the treatment of pediatric patients with neuroblastoma and has licensed the worldwide rights for this product exclusively to EUSA Pharma Ltd.. APEIRON uses its proprietary master checkpoint blockade mechanism to enable the human body's natural defense mechanisms to fight the tumor. APEIRON's clinical program APN401 is a “first-in-class” autologous cell therapy to strengthen immune reactivity via an intra-cellular master checkpoint, Cbl-b. APEIRON is developing APN01 in an ongoing clinical trial in Europe for the treatment of Covid-19 (alunacadase alfa). APEIRON's projects and technologies are based on a strong patent portfolio. Partnerships with leading pharmaceutical companies and academic institutions underline the development competence of APEIRON.

We are searching for our main office in Vienna an enthusiastic

Intellectual Property Manager (m/f)
(part-time)

Your responsibilities:

Your profile:

We offer:

If you enjoy working in a motivated team with an open and friendly corporate culture we are looking forward to receiving your application (incl. Curriculum vitæ and photo). Please note that we will focus our interview process based on a willingness to work in Vienna.

For the position we offer at least an annual gross salary of € 80.000, - (on full time basis). The actual remuneration package will be based on your professional experience, qualification and skills.
For more insights into Apeiron Biologics please go to www.apeiron-biologics.com
Contact: Head of HR, Elena Pretterebner
Email: jobs@apeiron-biologics.com
APEIRON Biologics AG, Campus-Vienna-Biocenter 5, 1030 Vienna